On Friday, Opus Genetics Inc (NASDAQ: IRD) opened at On Friday, higher 4.00% from the last session, before settling in for the closing price of $1.00. Price fluctuations for IRD have ranged from $0.65 to $2.18 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 60.62% at the time writing. With a float of $39.42 million, this company’s outstanding shares have now reached $45.48 million.
The firm has a total of 18 workers. Let’s measure their productivity. In terms of profitability, gross margin is 99.91%, operating margin of -564.72%, and the pretax margin is -523.4%.
Opus Genetics Inc (IRD) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Opus Genetics Inc is 33.93%, while institutional ownership is 22.78%. The most recent insider transaction that took place on Dec 26 ’24, was worth 97,600. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.98, taking the stock ownership to the 599,150 shares. Before that another transaction happened on Nov 21 ’24, when Company’s President bought 10,000 for $0.98, making the entire transaction worth $9,834. This insider now owns 342,800 shares in total.
Opus Genetics Inc (IRD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 60.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.76% during the next five years compared to 24.32% growth over the previous five years of trading.
Opus Genetics Inc (NASDAQ: IRD) Trading Performance Indicators
Check out the current performance indicators for Opus Genetics Inc (IRD). In the past quarter, the stock posted a quick ratio of 1.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Opus Genetics Inc (IRD)
Analysing the last 5-days average volume posted by the [Opus Genetics Inc, IRD], we can find that recorded value of 8.84 million was better than the volume posted last year of 0.6 million. As of the previous 9 days, the stock’s Stochastic %D was 8.97%. Additionally, its Average True Range was 0.12.
During the past 100 days, Opus Genetics Inc’s (IRD) raw stochastic average was set at 35.45%, which indicates a significant increase from 13.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.55% in the past 14 days, which was lower than the 75.15% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9180, while its 200-day Moving Average is $1.1040. Now, the first resistance to watch is $1.1036. This is followed by the second major resistance level at $1.1672. The third major resistance level sits at $1.2390. If the price goes on to break the first support level at $0.9682, it is likely to go to the next support level at $0.8964. Should the price break the second support level, the third support level stands at $0.8328.
Opus Genetics Inc (NASDAQ: IRD) Key Stats
There are currently 59,661K shares outstanding in the company with a market cap of 62.05 million. Presently, the company’s annual sales total 10,990 K according to its annual income of -57,530 K. Last quarter, the company’s sales amounted to 4,370 K and its income totaled -8,190 K.
